Recent Quotes

My Watchlist

Indicators

REGENXBIO Inc. - Common Stock (NQ:RGNX)

7.520 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1
Open	7.520
Bid (Size)	6.400 (2)
Ask (Size)	9.400 (1)
Prev. Close	7.520
Today's Range	7.520 - 7.520
52wk Range	5.035 - 16.85
Shares Outstanding	43,466,186
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

March 26, 2025

Via Benzinga

Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial

March 19, 2025

Regenxbio's RGX-202 gene therapy shows promising results in Duchenne muscular dystrophy, with high microdystrophin levels and a well-tolerated safety profile.

Via Benzinga

Performance

YTD	-4.3%	-4.3%
1 Month	+27.7%	+27.7%
3 Month	-4.7%	-4.7%
6 Month	-34.9%	-34.9%
1 Year	-52.2%	-52.2%

More News

Signet Jewelers, BGM Group, StoneCo, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

March 19, 2025

Via Benzinga

Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday

March 14, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Regenxbio Through 7 Analysts

February 11, 2025

Via Benzinga

Regenxbio Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

January 15, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025

Today 4:32 EDT

Via Benzinga

What to Expect from Regenxbio's Earnings

May 09, 2025

Via Benzinga

The One-Minute Market Report - Saturday, April 26

April 26, 2025

Via Talk Markets

Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost

April 21, 2025

Via Investor's Business Daily

What's going on in today's after hours session

March 31, 2025

Via Chartmill

Where Regenxbio Stands With Analysts

December 11, 2024

Via Benzinga

5 Analysts Have This To Say About Regenxbio

November 15, 2024

Via Benzinga

What 4 Analyst Ratings Have To Say About Regenxbio

October 10, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Regenxbio Through 5 Analysts

March 14, 2025

Via Benzinga

Earnings Scheduled For March 13, 2025

March 13, 2025

Via Benzinga

Assessing Regenxbio: Insights From 5 Financial Analysts

September 04, 2024

Via Benzinga

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns

February 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

January 14, 2025

Via Benzinga

Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

January 14, 2025

Via Benzinga

Workday, Apollo Global To Join S&P 500 Index In Quarterly Balance

December 06, 2024

Via Investor's Business Daily

What's Going On With REGENXBIO Shares Monday?

November 18, 2024

Via Benzinga

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

November 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 06, 2024

Via Benzinga

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

Via FinancialNewsMedia

Frequently Asked Questions

Is REGENXBIO Inc. - Common Stock publicly traded?

Yes, REGENXBIO Inc. - Common Stock is publicly traded.

What exchange does REGENXBIO Inc. - Common Stock trade on?

REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for REGENXBIO Inc. - Common Stock?

The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market

What is the current price of REGENXBIO Inc. - Common Stock?

The current price of REGENXBIO Inc. - Common Stock is 7.520

When was REGENXBIO Inc. - Common Stock last traded?

The last trade of REGENXBIO Inc. - Common Stock was at 05/09/25 04:00 PM ET

What is the market capitalization of REGENXBIO Inc. - Common Stock?

The market capitalization of REGENXBIO Inc. - Common Stock is 326.87M

How many shares of REGENXBIO Inc. - Common Stock are outstanding?

REGENXBIO Inc. - Common Stock has 327M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.